Bluejay Diagnostics (BJDX) Shares Outstanding (Weighted Average) (2020 - 2026)
Bluejay Diagnostics recorded quarterly Shares Outstanding (Weighted Average) of $271277.0 in Q1 2026, down 39.59% quarter-over-quarter from $449043.0 in Q4 2025, and up 95.86% year-over-year from $138503.0 in Q1 2025.
Bluejay Diagnostics' Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $271277.0 for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 95.86% year-over-year to $271277.0; the TTM figure through Mar 2026 stood at $271277.0 (up 95.86% YoY), while the FY2025 annual figure was $449043.0, up 879.42% from the prior year.
- Shares Outstanding (Weighted Average) came in at $271277.0 for Q1 2026 at Bluejay Diagnostics, down from $449043.0 in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $68.6 million in Q3 2024 to a low of $540.0 in Q3 2025.
- A 5-year average of $5.8 million and a median of $271277.0 in 2026 frame the typical range for Shares Outstanding (Weighted Average).
- Across the five-year window, Shares Outstanding (Weighted Average) soared 52267.19% in 2024 and tumbled 100.0% in 2025, its largest moves.
- Bluejay Diagnostics' Shares Outstanding (Weighted Average) stood at $1.0 million in 2022, then plunged by 99.73% to $2741.0 in 2023, then jumped by 1572.67% to $45848.0 in 2024, then surged by 879.42% to $449043.0 in 2025, then plunged by 39.59% to $271277.0 in 2026.
- According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $271277.0, $449043.0, and $540.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | 271,277.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 271,277.00 |
| Dec 31, 2025 | 449,043.00 |
| Sep 30, 2025 | 540.00 |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 138,503.00 |
| Dec 31, 2024 | 45,848.00 |
| Sep 30, 2024 | 68.63 Mn |
| Jun 30, 2024 | 3.35 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 2,741.00 |
| Sep 30, 2023 | 131,054.00 |
| Jun 30, 2023 | 127,881.00 |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | 124,200.00 |
| Jun 30, 2022 | 3,770.00 |
| Mar 31, 2022 | 20.14 Mn |
| Dec 31, 2021 | 128,438.00 |
| Sep 30, 2021 | 6.32 Mn |
| Jun 30, 2021 | 4.20 Mn |
| Mar 31, 2021 | 3.15 Mn |
| Dec 31, 2020 | 3.15 Mn |
| Sep 30, 2020 | 3.15 Mn |